Who owns HALOZYME THERAPEUTICS INC NOTE 1.000 8/1?
- CUSIP Number: 40637haf6
Tip: Access positions for across all investors
Analyze quarterly positions in Halozyme Therapeutics Inc Note 1.000 8/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Halozyme Therapeutics Inc Note 1.000 8/1 stock
Who bought or sold HALOZYME THERAPEUTICS INC NOTE 1.000 8/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Millennium Management | 89M | $125M | 72% | Sep 2025 |
|
| Point72 Asset Management | 41M | $54M | 41% | Dec 2025 |
|
| LMR Partners | 41M | $54M | -19% | Dec 2025 |
|
| Balyasny Asset Management | 35M | $49M | 100% | Sep 2025 |
|
| Alberta Investment Management Corporation | 35M | $47M | 100% | Dec 2025 |
|
| Jain Global | 25M | $33M | 25% | Dec 2025 |
|
| Jpmorgan Chase & Co | 22M | $31M | 100% | Sep 2025 |
|
| Lazard Asset Management | 17M | $226k | 1% | Dec 2025 |
|
| Lombard Odier Asset Management | 16M | $21M | 100% | Dec 2025 |
|
| Absolute Investment Advisers | 14M | $19M | 0% | Dec 2025 |
|
| Citadel Advisors | 14M | $20M | -29% | Sep 2025 |
|
| Linden Advisors | 13M | $17M | 0% | Dec 2025 |
|
| Calamos Advisors | 12M | $16M | -71% | Dec 2025 |
|
| Tenor Capital Management | 11M | $15M | 100% | Sep 2025 |
|
| Wells Fargo & Company | 9.7M | $13M | -20% | Dec 2025 |
|
| State Street Corporation | 9.6M | $13M | -32% | Dec 2025 |
|
| FMR | 9.5M | $13M | -12% | Sep 2025 |
|
| Franklin Resources | 8.1M | $11M | -9% | Dec 2025 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 8.1M | $11M | 0% | Dec 2025 |
|
| Warberg Asset Management | 8.0M | $11M | 56% | Dec 2025 |
|
| Ofi Invest Asset Management | 6.8M | $7.7M | 0% | Dec 2025 |
|
| SSI Investment Management | 6.1M | $8.1M | 0% | Dec 2025 |
|
| BlackRock | 5.8M | $7.6M | -17% | Dec 2025 |
|
| Union Bancaire Privee, UBP SA | 4.8M | $5.4M | 9% | Dec 2025 |
|
| Invesco | 4.5M | $6.0M | 12% | Dec 2025 |
|
| Lord, Abbett & Co | 3.7M | $4.9M | 100% | Dec 2025 |
|
| Walleye Trading Advisors | 3.0M | $4.0M | -33% | Dec 2025 |
|
| State of Wisconsin Investment Board | 3.0M | $4.0M | 0% | Dec 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 2.6M | $3.4M | 0% | Dec 2025 |
|
| Colony | 2.3M | $3.0M | 100% | Dec 2025 |
|
| Sonora Investment Management Group | 2.2M | $3.2M | -2% | Sep 2025 |
|
| Capital World Investors | 2.2M | $2.9M | 0% | Dec 2025 |
|
| Groupama Asset Managment | 2.0M | $2.7M | 100% | Dec 2025 |
|
| Toronto-Dominion Bank | 1.7M | $2.4M | -35% | Sep 2025 |
|
| Man Group | 1.7M | $2.2M | -18% | Dec 2025 |
|
| Agf Management | 1.5M | $2.0M | 0% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 1.4M | $1.9M | -81% | Dec 2025 |
|
| Barclays | 1.2M | $1.6M | 100% | Dec 2025 |
|
| Leucadia National Corporation | 1.2M | $1.6M | -77% | Dec 2025 |
|
| Palisade Capital Management | 1.1M | $1.5M | -32% | Sep 2025 |
|
| Goldman Sachs Group | 900k | $1.2M | 100% | Dec 2025 |
|
| Zurcher Kantonalbank | 700k | $946k | -30% | Dec 2025 |
|
| Dnca Finance | 630k | $839k | 0% | Dec 2025 |
|
| Bank of New York Mellon | 610k | $810k | 22% | Dec 2025 |
|
| Royal Bank of Canada | 320k | $451k | -82% | Sep 2025 |
|
| Central Pacific Bank - Trust Division | 317k | $421k | 0% | Dec 2025 |
|
| Advent Capital Management | 232k | $309k | -97% | Dec 2025 |
|
| Russell Investments | 232k | $309k | 0% | Dec 2025 |
|
| Virtus ETF Advisers | 65k | $86k | 0% | Dec 2025 |
|
| Steward Partners Investment Advisory | 6.0k | $8.0k | 0% | Dec 2025 |
|
| Us Bancorp | 5.0k | $6.6k | 0% | Dec 2025 |
|
| Loomis, Sayles and | 4.5k | $300k | 25% | Dec 2025 |
|
| Alken Asset Management | 2.0k | $2.7M | 0% | Dec 2025 |
|
| UBS Group | 1.3k | $1.8k | 0% | Dec 2025 |
|
Who sold out of Halozyme Therapeutics Inc Note 1.000 8/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Camden Asset Management | Sep 2025 | 35M | $50B |
| DLD Asset Management | Sep 2025 | 30M | $42M |
| Davidson Kempner Capital Management | Sep 2025 | 25M | $35M |
| Nuveen | Sep 2025 | 18M | $25M |
| Two Sigma Investments | Jun 2025 | 9.0M | $10M |
| UBS O'Connor | Sep 2025 | 7.0M | $9.9M |
| Susquehanna Advisors Group | Sep 2025 | 5.0M | $70k |
| Kohlberg Kravis Roberts & Co | Jun 2025 | 3.5M | $4.0B |
| RWC Asset Management | Sep 2025 | 2.3M | $3.3M |
| Prospector Partners | Sep 2025 | 1.2M | $1.7M |
| Westwood Holdings | Sep 2025 | 1.0M | $1.4M |
| Shenkman Capital Management | Sep 2025 | 900k | $1.3B |
| Bnp Paribas Arbitrage, Snc | Sep 2025 | 611k | $862k |
| Jane Street | Sep 2025 | 425k | $603k |
| Flossbach Von Storch | Sep 2025 | 200k | $282k |
| Fifth Third Bancorp | Sep 2025 | 10k | $1.4M |
| Boussard & Gavaudan Investment Management | Sep 2025 | 2.1k | $3.0M |